1. Hanbyoel L, Wonshik H. Unique features of young age breast cancer and its management. J Breast Cancer2014; 17: 301-30. doi.10.4048/jbc.2014.17.4.301 2. Comşa S, Cîmpean A M, Raica M. The story of MCF-7 breast cancer cell line 40 years of experience in research. Anticancer Res2015; 35: 3147-54. doi.0250-7005/2015 $2.00+.40 3. Wakharde AA, Awad AH, Bhagat A, Karuppayil SM. Synergistic activation of doxorubicin against cancer a review. Am J Clin Microbiol Antimicrob2018; 1: 1009. 4. Mizutani H, Oikawa S, Hiraku Y, Murata M, Kojima M, Kawanishi S. Distinct mechanisms of site specific oxidative DNA damage by doxorubicin in the presence of copper II and NADPH cytochrome P450 reductase.Cancer Sci 2003;94:686-91. doi.10.1111/j.1349-7006. 2003.tb01503. x. 5. Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mole Cancer Ther 2009; 8: 2821-32. doi.10.1158/1535-7163.MCT-09-0462 6. Kelleni MT, Amin EF, Abdelrahman AM. Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in Rats impact of oxidative stress inflammation and apoptosis. J Toxicol 2015; 1-8. doi. 10.1155/2015/424813 7. Rivankar S. An overview of doxorubicin formulations in cancer therapy. J Cancer Res Therap 2015; 10: 853. doi.10.4103/0973-1482.139267 8. Kalantari N, Ahangardarabi Z, Siadati S, Nikbakhsh N, Ghasemi M, Ghaffari T, et al. Detection of Toxoplasma gondii DNA in malignant breast tissues in breast cancer patients. Int J Mole Cell Med2017; 6: 190-6. doi.10.22088/acadpub.BUMS.6.3.190 9. Callejas B.E, Martínez-Saucedo D, Terrazas L.I. Parasites as negative regulators of cancer. Biosci Rep 2018; 38: 20180935. doi. 10.1042/BSR20180935 10. Soltanian S, Sheikhbahaei M, Mohamadi N. Cytotoxicity evaluation of methanol extracts of some medicinal plants on p19 embryonal carcinoma cells. J Appl Pharm Sci 2017; 7: 142-9. doi. 10.7324/JAPS.2017.70722 11. Shariatifar N, Mostaghim T, Afshar A, Mohammadpourfard I, Sayadi M, Rezaei M. Antibacterial properties of essential oil of Heracleum persicum Golpar and foodborne pathogens. Int J Enter Path2017; 5: 41-4. doi.10.15171/ijep.2017.10 12. Taghizabet N, Mangoli E, Anbari F, Masoodi SA, Talebi AR, Mazrooei M. The effect of Heracleum persicum Golpar oil and alcoholic extracts on sperm parameters and chromatin quality in mice. Int J Rep Biomed Yazd, Iran 2016; 14: 365-70. 13. Silveira FT, Blackwell JM, Ishikawa EA, Braga R, Shaw JJ, Quinnell RJ, et al. T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Parasite Immunol1998; 20: 19-26. doi.10.1046/j.1365-3024.1998.t01-1-00126.x 14. Bodo J, Chovancova J, Hunakova L, Sedlak J. Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate. Neoplasma 2005; 52: 510-6. 15. Azizi M, Bahadori M, Azizi F. History of cancer in Iran. Arch Iran Med 2013; 16: 613-22. 16. Thorn CF, Oshiro C, Marsh S, Hernandez T, Mcleod H, Klein TE, Altman RB. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharm Genom 2011; 21: 440-6. doi. 10.1097/FPC.0b013e32833ffb56 17. Smith L, Watson MB, Kane SLO, Drew PJ, Lind MJ, Cawkwell L. The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mole Cancer Therap 2006; 2115-21. doi.10.1158/1535-7163.MCT-06-0190 18. Lovitt CJ, Shelper TB, Avery VM. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer2018; 18: 41. doi. 10.1186/s12885-017-3953-6 19. Prakash O, Kumar A, Kumar P. Anticancer potential of plants and natural products a review. Am J Pharmacol Sci2013; 1: 104–115. doi: 10.12691/ajps-1-6-1 20. Bayala B, Bassole IHN, Scifo R, Gnoula C, Morel L. Anticancer activity of essential oils and their chemical components a review. Am J Cancer Res2014; 4: 591-607. doi. 2156-6976/ajcr0001130 21. Sadeghialiabadi H, Ahmad S, Saeidi M, Jafarian A. Cytotoxic effects of the extracts of iranian taxus baccata and cupressus horizentalis on cancer cells. Iranian J Pharmaceut Res2003; 2:107-10. doi. 10.22037/IJPR.2010.21 22. Filiz B, Songul K, Bostanlık D, Gul F, Ceyda Sibel K. Anticancer effect of ferulago mughlea peşmen apiaceae on cancer cell proliferation. Iran J Pharm Res 2016; 15: 501-4. 23. Holohan C, Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance an evolving paradigm. Nature Rev Cancer 2013; 13: 714-26. doi.10.1038/nrc3599 24. Mohammadi A, Baradaran B. [Apoptotic effect of the urtica dioica plant extracts on breast cancer cell line MDA- MB- 468]. J Ardabil Uni Med Scie2015; 15: 283-90. (Persian) 25. Elikaei A, Vazini H, Javani F. [Anticancer effects of parasite extracts of leishmaniasis and toxoplasma On resistant cell line A2780-CP and sensitive A2780 to cisplatin]. J Alzahra Uni Appl Biol2018; 31:23-8. doi. 10.22051/JAB.2017.16470.1162 (Persian) 26. Taqavi M, Nemati F, Khan Babaei R. Effect of glacial plant on cancer cell apoptosis. 3th National Con Food Secu Tehran Iran. 2013.
|